RLAY

Conviction 62HealthcareScan · Thu, Sep 24, 2026

Relay Therapeutics, Inc. (RLAY) closed at $17.73 (-1.69%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 40, RS Rating 98, -14.6% from its 52-week high, +116.7% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

RLAY$17.73-1.69%

ResistanceSupportVol 14Insider sell

Vol MA14 4.25M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Relay Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.relaytx.com ↗

Price17.73

Change-1.69%

Gap+0.39%

Rel volume2.10×

Avg volume3.74M

Avg $ vol69.98M

SMA 2018.77

SMA 5019.24

SMA 20013.70

Price vs 50-7.85%

Price vs 200+29.39%

MA stackmixed

50/200 cross—

Supertrenddown · 20.62

RSI (14)40

MACD hist-0.10

MACD cross—

Stoch %K / %D20 / 44

ADX (14)17

+DI / −DI14 / 25

RSI divergence—

MACD divergence—

ATR %5.32%

ADR %4.32%

52w high20.75

52w low4.38

From 52w high-14.58%

Above 52w low+304.68%

New 52w highNo

SqueezeOn · 6d

Bollinger width9.07%

%B-0.11

Donchian pos20.45%

Donchian high19.69

Donchian low17.22

AVWAP (52w high)18.93

vs AVWAP high-6.39%

AVWAP (52w low)13.14

vs AVWAP low+34.85%

OBV trendDown

Chaikin MF (20)-0.11

Today vs 20d2.10×

Avg vol (14d)4.25M

Avg vol (20d)3.74M

Avg $ vol (20d)69.98M

Market cap3.88B

RS Rating98 / 99

RS 3m (vs SPY)-5.08%

RS 6m (vs SPY)+67.82%

RS line new highNo

Trend template6/8

Technical rank67.1

1 week-7.63%

1 month-13.83%

3 months-0.59%

6 months+84.64%

1 year+298.31%

YTD+116.69%

P/E-14.05

P/B4.36

P/S252.97

P/FCF-16.47

EPS-1.61

Div yield—

ROE-31.06%

ROA-28.58%

Debt/Eq—

Current18.27

EV/EBITDA—

Gross margin—

Net margin—

Rev growth53.44%

EPS growth18.13%

Price target27.63

Target upside55.88%

Analyst ratingBuy

Institutional117.04%

Ent. value3.76B

Revenue350K

Net income-83.71M

Gross profit—

Free cash flow-235.87M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out191.59M

Employees192

ListedThu, Jul 16, 2020

Free float116.71M

Float %65.3%

Short interest43.55M

Days to cover16.7d

Short volume68.0%

Squeeze score99 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.41 vs −$0.41

Last surprise0.0% beat

Setup gradeB

Conviction62 / 100

Pattern quality—

Tech rank67.1 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance21.02

Support18.05

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RLAY

All disclosures →

No recent disclosed trades by Congress in RLAY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RLAY · open-market 10 sells

Insider	Side	Shares	Value	Traded	Filed
Bergstrom Donald A President, R&D · Common Stock · 2026-09-08	Sell	8.53K	$162K	2026-09-08	2026-09-09
Patel Sanjiv President and CEO · Common Stock · 2026-09-08	Sell	48.2K	$913K	2026-09-08	2026-09-09
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-09-08	Sell	17.72K	$336K	2026-09-08	2026-09-09
Rahmer Peter See remarks · Common Stock · 2026-08-26	Sell	4.51K	$90K	2026-08-26	2026-08-28
SVF Pauling (Cayman) Ltd 10% owner · Common Stock · 2026-08-25	Sell	6M	$116M	2026-08-25	2026-08-28
Patel Sanjiv President and CEO · Common Stock · 2026-08-17	Sell	48.2K	$980K	2026-08-17	2026-08-18
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-08-14	Sell	17.72K	$350K	2026-08-14	2026-08-18
Patel Sanjiv President and CEO · Common Stock · 2026-07-07	Sell	48.2K	$944K	2026-07-07	2026-07-08
Bergstrom Donald A President, R&D · Common Stock · 2026-07-06	Sell	8.66K	$162K	2026-07-06	2026-07-08
Catinazzo Thomas Chief Financial Officer · Common Stock · 2026-07-06	Sell	17.72K	$331K	2026-07-06	2026-07-08

SEC filings

EDGAR filings in RLAY · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.